Teachers Training Anuradhapura Education Zone
A training workshop on drug prevention and counseling for 64 teachers engaged in counseling in the Anuradhapura Education Zone was held on the 16th of October 2024 at the Anuradhapura...
NDDCB is registered as an education provider in ISSUP International. By design, the Colombo Plan DAP will update the capacity of the NDDCB and other agencies to control drug demand and supply. Majority of NDDCB staff members have completed...
The Colombo Plan Drug Advisory Programme (DAP) launched a new prevention initiative to address the need for competent professionals involved in drug use prevention across Central Asia. The first training aimed at prevention practitioners...
When women gather, emotions tend to swell. But on this particular day at the Empower Her Recovery Centre- Nueva Annex, the tears that flowed were not of pain or struggle. They were tears of triumph. It was September 27th September 2024, and...
This article describes the quality of Spanish family support programs, focusing on their impact, community reach, expansion, and sustainability. EurofamNet selected 57 programs that had evidence-based results. Family support programmes...
Objective: Ayahuasca, a plant-based substance from the Amazon, is gaining attention for its potential in treating addiction. However, there is little research on the role of purging (mainly vomiting), which is a key part of the healing...
A study funded by the NIH found that adults with opioid use disorder (OUD) who take higher doses of buprenorphine, an opioid addiction treatment medication, have a lower risk of emergency department or inpatient visits related to behavioral...
Importance Although cases of neonatal opioid withdrawal syndrome (NOWS) increased 5-fold in recent years, no study has examined national hospital readmission rates for these infants.
Objective To examine hospital readmissions...
Importance Prescribing medications for opioid use disorders (MOUD), including buprenorphine, naltrexone, and methadone, to adolescents remains an underused evidence-based strategy for reducing harms associated with opioid use.
O...
Importance In 2023, more than 80 000 individuals died from an overdose involving opioids. With almost two-thirds of the US jail population experiencing a substance use disorder, jails present a key opportunity for providing...
Resumen
Introducción. La demanda de oferta terapéutica por consumo de metanfetamina (cristal) en el estado de Aguasca- lientes, México se ha incrementado en los últimos años. El cristal se ha convertido en la principal droga de impacto en...
New Orleans, June 14-18, 2025
The CPDD meeting is an in-person meeting with no digital participation options.
Symposium, Mini-Symposium, Workshop, and Forum
Deadline: Friday, October 18, 2024
The Fogarty International Center of the U.S. National Institutes of Health (NIH) and partner organizations will host a Global Forum on Humanitarian Health Research (GFH2R) inclusive of public webinars and an in-person meeting in May 2025...
Chronic non-cancer pain (CNCP) is one of the most common causes of disability globally. Opioid prescribing to treat CNCP remains widespread, despite limited evidence of long-term clinical benefit and evidence...
The COVID-19 pandemic has impacted how people access medications for opioid dependence. Researchers looked at monthly changes in several factors related to buprenorphine/naloxone (BNX) treatment over 56 months, including before...
The study analyzed national data from the U.S. to track trends in cannabis use from 2013 to 2021, focusing on changes in use among young and middle-aged adults. Researchers also looked at whether these trends varied by sociodemographic...
The World Health Organization (WHO) uses risk drinking levels (low, moderate, high, and very high risk) as a measure for reducing alcohol consumption in clinical trials. However, these levels have not been specifically evaluated for...
